Preliminary Program: Monday, May 18
7 a.m.-8:30 a.m.
Industry-Supported Breakfast Symposia
Residents' Session
Meet the Experts: Sunny-Side Up
7 a.m.-5 p.m.
Registration/Course Enrollment Open
8 a.m.-Noon
CME Courses 34-41
9 a.m.-10:30 a.m.
Small Interactive Sessions
SI01. Safety Issues in Child Psychopharmacology Barbara Coffey, M.D.
SI02. Antipsychotic Polypharmacy: An Evidence-Based Perspective Donald Goff, M.D.
Focus Live
FL01. FOCUS LIVE! Geriatric Psychiatry Barry Lebowitz, Ph.D.
Lecture
L03. Pills to Treat Alcoholism Bankole A. Johnson, M.D., Ph.D., D.S., Solomon Carter Fuller Award Lecture
L04. Psychiatrists' Role in Prevention and Intervention in Domestic Violence Among South Asians Surinder Sucha Nand, M.D., Alexandra Symonds Award Lecture
L05. Psychiatric Genetics: A Current Perspective Kenneth Kendler, M.D., Distinguished Psychiatrist Lecture
L06. Etiology in Psychiatry: Phenomes, Genomes, and Epigenomes James Potash, M.D., Frontiers of Science Lecture
Poster Session 1 New Research/Young Investigators
Case Conferences (Open to APA members only)
CC01. Shame and Forgiveness Melvin Lansky, M.D.
CC02. A Population-Based Case Conference Illustrating the Implementation of an Evidence-Based Prevention Intervention in a Country With 200,000 People Carl Bell, M.D.
Debate/Roundtable
DR01. To Be Announced
Component Workshops
CW01. High-Risk Student Populations: Innovative Approaches to Treatment and Outreach Chair: Jerald Kay, M.D.
CW02. Lost and Not Found: Depression and Suicide in Elderly Asian Americans APA Committee of Asian-American Psychiatrists; Chair: Jacquelyn Chang, M.D.
CW03. A Family-Related Approach to Reducing Risk and Promoting Well-Being Among LGBT Youth Association of Gay and Lesbian Psychiatrists; Chair: Ellen Haller, M.D.
CW04. International Disasters: Challenges and Opportunities to Contribute APA Committee on Psychiatric Dimensions of Disaster; Chair: Shirley Liu, M.D., Co-Chair: Patcho Santiago, M.D.
CW05. Career Advancement in Administrative Psychiatry for Early Career Psychiatrists APA Assembly Committee of Early Career Psychiatrists; Chair: Dimitri Markov, M.D., Co-Chair: Marina Goldman, M.D.
CW06. Show Me the Money! Sustainable Funding for Education in Psychiatry APA/GlaxoSmithKline Fellows; Chair: M. Justin Coffey, M.D.
Issue Workshops
IW01. Increasing Cultural Competency to Assess and Ameliorate Distress of Diverse Patients: Example From the Care of a South Asian Victim of Spousal Abuse Chair: Jacob Sperber, M.D., Co-Chair: Nyapati Rao, M.D.
IW02. Practical Pharmacotherapy for the Treatment of Alcohol Dependence National Institute on Alcohol Abuse and Alcoholism; Chair: Robert Swift, M.D., Co-Chair: Allen Zweben
IW03. Incest—a Cultural Perspective APA Council on Global Psychiatry and the APA Council on Children, Adolescents, and Their Families; Chair: Rodrigo A. Muñoz, M.D.
IW04. Playing in the Big League: Resident Leadership in the APA Board of Trustees Chair: Molly McVoy, M.D., Co-Chair: Lauren Sitzer, M.D.
IW05. Risk Management Issues in Psychiatric Practice Chair: Martin Tracy, J.D., Co-Chair: Jacqueline Melonas, J.D.
IW06. Ethical, Clinical, and Legal Challenges Chair: Malkah Notman, M.D., Co-Chair: Linda Jorgenson, J.D.
IW07. Technology and Psychiatry: Practical and Clinical Tips for Using Telepsychiatry (Open to residents only) APA/Shire Fellowship Program; Chair: Jena Worley, M.D., Co-Chair: Michael Houston, M.D.
IW08. Mindful Practice: Understanding Its Role in Psychiatry and Psychiatric Training Chair: Tana Grady-Weliky, M.D.
IW09. Need to Reformulate “Risk” and Its“ Assessment” in Clinical Practice World Psychiatric Association; Chair: Amresh K. Shrivastava, M.D.
IW10. Imaging Insight: Basic Definitions, Measures, and Relevance to Psychopathology National Institute on Drug Abuse; Chair: Steven Grant, Ph.D., Co-Chair: Rita Goldstein
IW11. Implementing a Telepsychiatry Program in the Kern County Mental Health System in Rural California (Part 2) Chair: Salvador del Rosario, M.D., Co-Chair: Tai Yoo, M.D.
IW12. Using the DSM-IV-TR Cultural Formulation for Cultural Competence Skill Building Among Psychiatry Residents Chair: Treniece Lewis Harris, Ph.D., Co-Chair: Marshall Forstein, M.D.
IW13. Diversion of Prescription StimulantsNational Institute on Drug Abuse; Chair: Moira O'Brien, Co-Chair: Wilson Compton III, M.D.
9 a.m.-Noon
Advances In Research
AR01. Advances in ResearchHerbert Pardes, M.D.
9 a.m.-12:30 p.m.
Media Workshop
MW1. Ready? OK! A Film About Childhood Gender Variance American Academy of Child and Adolescent Psychiatry; Chair: Richard Pleak, M.D., Co-Chair: Sarah Herbert, M.D.
MW2. Silver Spurs—Severe and Chronic Mental Illness, and Life in a Residential Care FacilityChair: Steven Harvey, M.D., Co-Chair: Doug Whyte, B.S.
9 a.m.-4 p.m.
CME Courses 42-49
CKS03. NEW! Clinical Knowledge and Skills Series Advances in Neuropsychiatry Presented by C. Edward Coffey, M.D.
10 a.m.-5:30 p.m.
Exhibits Open
APA Member Center Open
Publishers' Bookfair Open
11 a.m.-12:30 p.m.
Advances in Medicine
AM01. The Top 10 Medical Articles of 2008: A Comprehensive and Practical Review of What We Need to Know Monique Yohanan, M.D.
Focus Live
FL02. FOCUS LIVE! PTSD and Disaster Psychiatry Anand Pandya, M.D.
Forum
F01. DSM-V: Progress in Research and Development Chair: Darrel Regier, M.D. (DSM Track 01)
F02. The Relationship Between the APA and Pharmaceutical Industry Chair: Ken Silks, M.D.
F03. Developing the Next Generation of Clinical Translational Researchers: Innovation in an Academic Department of Psychiatry Chair: Renée Binder, M.D.
F04. Treating Women With Alcohol Use Disorders Chair: Grace Chang, M.D.
Lectures
L07. Psychiatric Education Across Civilization: The Search for a Guru and the IMG Nypati Rao, M.D., George Tarjan Award Lecture
L08. Mental Health in the New Era of Cost Control Richard Frank, M.D., Frontiers of Science Lecture
L09. To Be Announced Elyn Saks, J.D., Outside Lecture
Scientific and Clinical Reports
Session 1. Forensic Psychiatry
1. Characteristics of Mentally Ill Offenders From 100 Psychiatric Court Reports Yasser Elsayed, M.D., M.S.
2. Homicide and During the First Episode of Psychotic Illness Olav Nielssen, M.B.B.S.
3. Differences Between Men and Women Found Not Guilty By Reason of Insanity for Homicide Offenses at Napa State Hospital Jessica Ferranti, M.D.
Session 2. Measurement of Personality Disorder Severity
4. The Severity Indices of Personality Problems—A New Dimensional Questionnaire for Measuring (mal)Adaptive Personality Functioning Helene Andrea
5. Severity Indices of Personality Problems (SIPP-118) in Adolescents: Factor Structure and Validity Joost Hutsebaut, Ph.D.
6. The Severity Indices of Personality Problems (SIPP-118) as a Clinical Instrument Dineke Feenstra, M.A.
Session 3. Genetic, Neuroimaging, and Neuropsychological Studies in Schizophrenia
7. Does Aberrant Stimulus Salience Lead to Psychosis in Schizophrenia?: A 20-Year Longitudinal Study Martin Harrow, Ph.D.
8. Association of G-1438A Polymorphism of 5HT2A Receptor With Schizophrenia in Three Ethnic Groups in Malaysia Zahurin Mohamed, B.S.C., Ph.D.
9. MEG Analysis of Early Processing of Facial Expressions in Schizophrenia and Controls Stephen Lewis, M.D.
Session 4. Adjunctive Treatment and Comorbidity in Schizophrenia
10. Effects of Adjunctive Treatment With Armodafinil in Schizophrenia Ashwin A. Patkar, M.D.
11. Prevalence of Alcohol Use Disorders in Schizophrenia: A Systematic Review and Meta-Analysis Jouko Miettunen, Ph.D.
12. Zolpidem in Treatment-Resistant Catatonia: Case Reports and Literature Review Cristinel Coconcea, M.D.
Session 5. Psychopharmacology: Psychostimulant, Antidepressant Side Effects
13. Linking Attention-Deficit/Hyperactivity Disorder Ratings and Clinical Global Impressions Scores in Studies of Lisdexamfetamine Dimesylate in ADHD Richard Weisler, M.D.
14. Antidepressant-Induced Excessive Sweating (ADIES): Measurement and Treatment Rajnish Mago, M.D.
15. Armodafinil Once Daily Sustains Wakefulness Throughout the Day in Patients With Excessive Sleepiness Associated With Narcolepsy Thomas Roth, Ph.D.
Session 6. Bipolar Disorder
16. Who Receives Guideline-Based Pharmacotherapy for Bipolar Depression? Megan Ehret, Pharm.D.
17. Psychiatric Admissions and Hospitalization Costs in Bipolar Disorder in Sweden Anne Tiainen, M.P.H., R.N.
18. Symptoms and Treatment of Bipolar Disorder in Sweden Mats Adler, M.D.
Session 7. The Broad Reach of Psychiatry: Studying History, Peacekeeping, and the Role of Spirituality in Schizophrenia
19. The Modern History of American Psychiatry: Unintended Consequences Milton Kramer, M.D.
20. Is Peacekeeping Peaceful? A Systematic Review Jitender Sareen, M.D.
21. Spiritual and Religious Coping in Schizophrenia: Clinical Implications Philippe Huguelet, M.D.
Session 8. Studies in Psychotherapy
22. Follow-Up Psychotherapy Outcome of Patients With Dependent, Avoidant, and Obsessive-Compulsive Personality Disorders—a Meta-Analytic Review Witold Simon, M.D., Ph.D.
23. The Effectiveness of Evidence-Based Treatments for Major Depressive Disorder in a Routine Clinical Setting: Results From an Observational Study Frenk Peeters, M.D., Ph.D.
24. The Effectiveness of a Group-Oriented Inpatient CBT Program Katherine Lynch, Ph.D.
Small Interactive Sessions
SI03. Psychiatric Issues Related to Returning Vets From Iraq Charles Hoge, M.D.
Component Workshop
CW07. Revitalizing Service: Strategic Planning Success Within District Branches and State Associations APA Council on Member and District Branch Relations; Chair: Nioaka Campbell, M.D.
CW08. Combat to Community: Needs and Resources for Post-September 11th Veterans and Their Families APA Alliance; Chair: Kay Brada
CW09. Becoming a Public Psychiatry Leader: Mentoring Models for Everyone, From Residents to Medical Directors APA Council on Social Issues and Public Psychiatry; Chair: Peter Chien, M.D.
Issue Workshops
IW14. Challenging Stigmas & Stereotypes: Integrated Therapy for Multidiagnosed Addiction Patients Combining Innovative With Traditional Approaches Chair: Michael Scimeca, M.D.
IW15. Man- and Non-Man-Made Disasters in Asia: The Role of Resilience Chair: Pedro Ruiz, M.D.
IW16. Turning Lead Into Gold: Tragedy and Transformation in a Public Psychiatric Emergency Service Chair: Stephen M. Goldfinger, M.D., Co-Chair: Ellen Berkowitz, M.D.
IW17. Can Disclosure of a Diagnosis of Borderline Personality Disorder Help Guide Treatment for Clinicians, Patients, and Families? Chair: Richard G. Hersh, M.D.
IW18. Application of Cultural Variables for Practice of Effective Psychotherapy of Indians Settled in U.S.A. Chair: Nitin Gupta, M.D., Co-Chair: Vijoy Varma, M.D.
IW19. Cognitive Therapy for Psychosis in Practice by Psychiatrists: Basic Techniques Chair: Shanaya Rathod, M.D., Co-Chair: Douglas Turkington
IW20. Resident Wellness Survey Results and DiscussionChair: Paul O'Leary, M.D., Co-Chair: Hind Benjelloun, M.D.
12:30 p.m.-2 p.m.
New Research Young Investigators' Poster Session 2
1 p.m.-5 p.m.
CME Courses 50-54
2 p.m.-3:30 p.m.
Advances In Series
A01. Neuropsychiatry Stuart Yudofsky, M.D.
A02. Psychopharmacology Alan Schatzberg, M.D., Charles Nemeroff, M.D.
A03. Substance Abuse Mark Galanter, M.D., Herbert Kleber, M.D.
Lecture
L10. Successful Aging and Wisdom: Are These for Real?Dillip Jeste, M.D., Distinguished Psychiatrist Lecture
2 p.m.-5 p.m.
DSM Track
DSM02. Evolution of the DSM-V Conceptual Framework: Development, Dimensions, Disability, Spectra, and Gender/Culture Chair: Darrell Regier, M.D.
Focus Live
FL03. FOCUS LIVE! Panic and Social Anxiety Disorder Mark Pollack, M.D.
Presidential Symposia
PS01. Is Psychiatry Better for Patients and Physicians in a Real Health Care System? Chair: Gisele Apter, M.D., Ph.D.
PS02. Psychiatrists' Relationships With IndustryChair: Paul Appelbaum, M.D., Co-Chair: Laura Roberts, M.D.
Symposia
S1. Spotting the Wolf in Sheep's Clothing: Clinical Challenges Identifying and Treating Unpresented Comorbidity National Institute on Drug Abuse
The Prevalence of Substance Use Disorders Among Psychiatric Populations Carlos Blanco-Jerez, M.D.
Screening for Substance Use Disorder Among Individuals With Severe Mental Illness Stanley D. Rosenberg, Ph.D.
Motivational Interviewing for Substance Abuse Among Adolescents With Psychiatric Comorbidity Richard A Brown, Ph.D.
Diagnosis Challenges for Co-Occurring ADHD and Substance Use Disorders Frances Levin, M.D.
The Treatment of Co-Occurring Mood and Anxiety Disorders in Addictions Kathleen Brady, M.D.
S2. Adjustment Disorders: Problems in Conceptualization, Conundrums in Classification
Adjustment Disorders and DSM-V: Considerations for Dimensional (Spectrum Diagnoses) Versus Categorial James J. Strain, M.D.
Recent Advances in the Study of Adjustment Disorders Andreas Maercker, M.D.
Can Adjustment Disorder and Depressive Episode Be Distinguished? Results From the ODIN Study Patricia P. Casey, M.D.
Posttraumatic Embitterment Disorder Michael Linden, M.D.
S3. Delivering Psychiatry in Rural Peru: The Ayacucho Mental Health Project
The Ayacucho Mental Health Project James Phillips, M.D.
Constructing a Formulary for a Psychiatric Clinic in the Developing World Mark D. Rego, M.D.
Psychiatric Treatment in a Trilingual Setting Stephen J. Bittner, M.D.
The Use of Skype by the Ayacucho Team in Follow-Up, Supervision, and Other Contacts With Patients and Staff Galen W. Stahle, M.D.
Evaluation of Change in Indicators of Mental Health in an Andean Region of Peru Luis E. Bedregal, Ph.D.
S4. Stalking: Risk Management and Treatment of Offenders and Victims
A Comprehensive Approach to the Treatment of Stalking Victims Gail E. Robinson, M.D.
Stalking of Health Care Professionals Karen M. Abrams, M.D.
Treatment of Stalking Offenders Werner Tschan, M.D.
Workplace Assessment of Violence Risk Stephen G. White, Ph.D.
Stalking Threat Management Jeffrey Dunn, M.D.
S5. Understanding and Addressing Adolescent Alcohol Consumption and Alcohol Use Disorders in the Context of Overall Development National Institute on Alcohol Abuse and Alcoholism
Early Development and Continuity of Risk for Early Drinking, Problem Drinking, and Alcoholism From Early Childhood to Adulthood Robert A. Zucker, Ph.D.
Applying a Developmental Framework to Alcohol-Related Behaviors: Ages 10-15 Michael Windle, Ph.D.
Applying a Developmental Framework to Alcohol-Related Behaviors From Middle to Late Adolescence Sandra A. Brown, Ph.D.
Developmentally Informed Research on the Effectiveness of Clinical Trials (DIRECT) With Adolescents With Alcohol Problems Eric F. Wagner, Ph.D.
Evidenced-Based Treatments for Alcohol Use Disorders in Adolescents Deborah Deas, M.D., M.P.H.
S6. “In or Out?”: A Discussion About Gender Identity Diagnoses and the DSM (DSM Track DM03)
The DSM-V Revision Process: Principles and Progress William E. Narrow, M.D.
Beyond Conundrum: Strategies for Diagnostic Harm Reduction Kelley Winters, Ph.D.
Aligning Bodies With Minds: The Case for Medical and Surgical Treatment of Gender Dysphoria Rebecca Allison, M.D.
The Role of Medical and Psychological Discourse in Legal and Policy Advocacy for Transgender Persons in the U.S. Shannon P. Minter, J.D.
S7. Relationship of Subthreshold Psychiatry to Axis II (Personality Disorders)
Relationship of Subthreshold Psychiatry to Personality Disorders Ahmed Okasha, M.D.
Personality Disorders, Their Thresholds, and Public Health Norman Sartorius, M.D.
Schizophrenia/Schizotaxia: A Genetic Predisposition of Schizophrenia Ming T. Tsuang, M.D.
On the Shared Diathesis of Borderline Personality and Bipolar Hagop S. Akiskal, M.D.
Generalized Anxiety Disorder and Avoidant Personality Disorder Juan J. Lopez-Ibor, M.D.
S8. Educating a New Generation of Physicians in Psychiatry: Reports From Winners of APA Innovative Teaching Grants APA Corresponding Committee on Medical Student Education
Changing Perspectives: Reducing the Stigma of Mental Illness in Medical Students Through the Living Museum Project Janis Cutler, M.D.
A School-Based Medical Student Curriculum for Education in Child and Adolescent Psychiatry Justine Larson, M.D.
Teaching Third-Year Medical Students Brief Motivational Interviewing Skills to Use in Counseling Patients With Mental Illness on Smoking Cessation Brenda J.B. Roman, M.D.
Preventing and Managing Metabolic Syndrome Among the Seriously Mentally Ill: Teaching Behavioral Medicine to Medical Students Jason B. Rosenstock, M.D.
S9. Effective Assessment and Treatment of Sexual Dysfunction in Adults and the Elderly
Clinical Presentation and Assessment of Sexual Dysfunction in Patients With Psychiatric Illness Jeffrey D. Raynor, M.D.
Treatment of Psychotropic-Induced Sexual Dysfunction Travis O. Bruce, M.D.
Sexual Dysfunction in Late Life: Beyond “Vitamin V” Shilpa Srinivasan, M.D.
S10. The Neurobiological Evidence for Transgenderism
Brain Gender Identity Sidney W. Ecker, M.D.
Transsexuality as an Intersex Condition Milton Diamond, Ph.D.
Novel Approaches to Endocrine Treatment of Transgender Adolescents and Adults Norman Spack, M.D.
S11. Comprehensive HIV Psychiatry Update
HIV/AIDS Medical Update Paul Volberding, M.D.
Neuropsychiatric Overview of HIV/AIDS Robert Daroff Jr., M.D.
Neurocognitive Decline Karl Goodkin, M.D.
Psychopharmacology Gabrielle Marzani-Nissen, M.D.
S12. The OC Spectrum in the Athlete: Psychopathology or Competitive Edge? International Society for Sport Psychiatry
An International-Level Athlete's Struggle With Obsessive-Compulsive Disorder David O. Conant-Norville, M.D.
Athletes and Superstition Thomas S. Newmark, M.D.
The OC Spectrum in the Athlete: Psychopathology or Competitive Edge Saul I. Marks, M.D.
S14. Increasing the Likelihood of Achieving Remission in Depression
Medication Algorithms for Antidepressant Treatment: Lessons Learned From STAR*D and Other Practical Clinical Trials Madhukar H. Trivedi, M.D.
Strategies for Medication Management of Treatment Resistance: Lessons From STAR*D Maurizio Fava, M.D.
Use of EEG Biomarkers to Direct Selection of Antidepressant Medication Andrew F. Leuchter, M.D.
Collaborative Care Approaches to Depression Jurgen Unutzer, M.D.
Can Genetic Biomarkers Help Direct Treatment for Depression? Gonzalo Laje, M.D.
S15. The Transmission of Borderline Personality Disorder
The Aggregation of DIB-R and DSM-IV Borderline Personality Disorder Mary C. Zanarini, Ed.D.
Familial Coaggregation of BPD With Axis I Disorders James I. Hudson, M.D.
Familial Aggregation of Attachment in Borderline Personality Disorder Lois W. Choi-Kain, M.D.
Familiality of BPD's Component Phenotypes John G. Gunderson, M.D.
An Endophenotypic Approach to Borderline Personality Disorder Larry J. Siever, M.D.
S16. Contributions of Neuroscience to Medications Development for Alcohol Use Disorder National Institute on Alcohol Abuse and Alcoholism
Novel Targets From the Dark Side of Dependence on Alcohol: Focus on CRF, Norepinephrine, and Vasopressin George F. Koob, Ph.D.
Activation of the Nociceptin/Orphanin FQ System Reduces Alcohol Abuse–Related Behaviors in Rats With Innate Predisposition to Excessive Alcohol Intake and Elevated Anxiety Roberto R.C. Ciccocioppo, Ph.D.
N-Type Calcium Channel Blockers for Alcohol Use Disorders: From Cells to People Robert O. Messing, M.D.
New Array of Potential Treatments for Alcohol Use Disorders: From Drosophila to Electophysiology and More Predictive Animal Models Selena E. Bartlett, Pharm.D.
The Emerging Role of Pharmacogenetics in Medications Development for Alcoholism: the Case of the Mu-Opioid Receptor Vijay A. Ramchandani, Ph.D.
S17. Monitoring Equity in Mental Health From a Cross-National Perspective
Equity in Determinants of Health and Health Policies Influencing Mental Health: A Cross-National Perspective Donna Stewart, M.D.
Monitoring Equity in Mental Health in Lower-, Middle-, and High-Income Countries Natalia Diaz-Granados, M.S.C.
Sociodemographic Factors Affect Mental Illness Rates Differently Across Countries Marta B. Rondon, M.D.
Factors Associated With Inequities in Mental Health Care Use in a Developing Country Javier E. Saavedra, M.D.
Income-Related Inequity in Mental Health Service Utilization in Colombia and Canada Marie DesMeules, M.S.C.
S18. Recovery and Rehabilitation: From the Provider and Patient Points of View in France and the U.S.: Vive la Difference!
Recovery From Disability of Serious Mental Disorders: A Phase-Linked Rehabilitation Process Robert P. Liberman, M.D.
Can We Implement Recovery and Rehabilitation?: What Do We Know and What Are the Implications for Services? Marianne D. Farkas, Sc.D.
An Individualized Cognitive Remediation Therapy for Patients With Schizophrenia: The RECOS Program Pascal Vianin, Ph.D.
Functional Remission in Schizophrenia: A Specific Tool for Evaluation Pierre Michel Llorca, M.D.
3 p.m.-5 p.m.
New Research/Young Investigator Session 3
5:30 p.m.-6:30 p.m.
Convocation of Distinguished Fellows
L11. To Be AnnouncedWilliam C.Menninger Memorial Lecture
7 p.m.-10 p.m.
Industry-Supported Symposia ▪
Information & Authors
Information
Published In
History
Published online: 20 February 2009
Published in print: February 20, 2009
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
Get Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).